Showing results (51-60 of 451) with videos related to
Sort By:
Pageof 46
The Journal of Biological Chemistry|April 23, 2003
Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic miceChristopher P Denton, Bing Zheng, Lowri A Evans, et al.Clinical and Experimental Rheumatology|October 13, 2015
Systemic sclerosis: from pathogenesis to targeted therapyChristopher P DentonClinical Medicine (London, England)|February 3, 2016
Advances in pathogenesis and treatment of systemic sclerosisChristopher P DentonClinical Medicine (London, England)|December 5, 2015
Advances in pathogenesis and treatment of systemic sclerosisChristopher P DentonArthritis Research & Therapy|September 15, 2007
Therapeutic targets in systemic sclerosisChristopher P DentonSeminars in Arthritis and Rheumatism|November 30, 2019
Challenges in systemic sclerosis trial designChristopher P DentonObstetric Medicine|October 23, 2020
Systemic sclerosis in pregnancyKristina En Clark, Oseme Etomi, Voon H OngArthritis Research & Therapy|September 7, 2021
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosisEmma Derrett-Smith, Kristina E N Clark, Xu Shiwen, et al.Clinical Reviews in Allergy & Immunology|August 13, 2016
The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive ReviewCecilia Beatrice Chighizola, Voon H Ong, Pier Luigi MeroniArthritis Research & Therapy|June 1, 2022
Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trialEdward P Stern, Lauren V Host, Ivy Wanjiku, et al.Pageof 46